Evotec SE (EVO)
NASDAQ: EVO · IEX Real-Time Price · USD
5.25
-0.24 (-4.37%)
At close: May 17, 2024, 4:00 PM
5.37
+0.12 (2.29%)
After-hours: May 17, 2024, 6:17 PM EDT
Evotec SE Employees
Evotec SE had 4,952 employees on December 31, 2022. The number of employees increased by 754 or 17.96% compared to the previous year.
Employees
4,952
Change (1Y)
754
Growth (1Y)
17.96%
Revenue / Employee
n/a
Profits / Employee
n/a
Market Cap
1.86B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2022 | 4,952 | 754 | 17.96% |
Dec 31, 2021 | 4,198 | 3,995 | 1,967.98% |
Dec 31, 2009 | 203 | 0 | - |
Dec 31, 2008 | 203 | 0 | - |
Dec 31, 2007 | 203 | -396 | -66.11% |
Dec 31, 2006 | 599 | -14 | -2.28% |
Dec 31, 2005 | 613 | -26 | -4.07% |
Dec 31, 2004 | 639 | -7 | -1.08% |
Dec 31, 2003 | 646 | 27 | 4.36% |
Dec 31, 2002 | 619 | 34 | 5.81% |
Dec 31, 2001 | 585 | 277 | 89.94% |
Dec 31, 2000 | 308 | 110 | 55.56% |
Dec 31, 1999 | 198 | 72 | 57.14% |
Dec 31, 1998 | 126 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
BrightSpring Health Services | 35,000 |
UFP Technologies | 3,093 |
Zai Lab | 2,175 |
Amphastar Pharmaceuticals | 1,761 |
Privia Health Group | 1,102 |
Beam Therapeutics | 507 |
Agios Pharmaceuticals | 386 |
Sana Biotechnology | 328 |
EVO News
- 3 days ago - Evotec SE to Announce Results for First Quarter 2024 on 22 May 2024 - Accesswire
- 19 days ago - Bayer and Evotec Collaborate to Advance Precision Cardiology - Accesswire
- 24 days ago - Evotec shares lose a third of their value on cloudy outlook - Market Watch
- 25 days ago - Evotec Presents Fiscal Year 2023 Results and Announces Priority Reset to Focus on Profitable Growth - Accesswire
- 25 days ago - Evotec SE appoints Dr Christian Wojczewski as Chief Executive Officer - Accesswire
- 4 weeks ago - Evotec and Variant Bio Enter Strategic Partnership to Discover and Develop Fibrosis Treatments - Accesswire
- 4 weeks ago - EVOTEC AND VARIANT BIO ENTER STRATEGIC PARTNERSHIP TO DISCOVER AND DEVELOP FIBROSIS TREATMENTS - PRNewsWire
- 4 weeks ago - Evotec SE to Announce Results for Fiscal Year 2023 on 24 April 2024 - Accesswire